Released: 4-Apr-2008 1:00 PM EDT
Co-Discoverer of p53 Suppressor Gene Honored at AACR
Rutgers Cancer Institute of New Jersey

Internationally recognized cancer researchers to be honored at AACR meeting in San Diego April 12 - 16. Dr. Arnold Levine to receive $100,000 Landon prize for p53 work, while Dr. Joseph Bertino to receive the Burchenal award for lifetime work on finding curative treatments for leukemia and lymphoma.

Released: 4-Apr-2008 1:00 PM EDT
Striving for Personalized Medicine in the World of High Tech
Rutgers Cancer Institute of New Jersey

A world-renowned leader in cancer bioinformatics, who is heading up a new program in New Jersey, will discuss translational implications of the intellectual marriage of math, science and computers at the annual AACR meeting in San Diego April 12 "“ 16.

Released: 4-Apr-2008 1:00 PM EDT
April 20-26 is National Minority Cancer Awareness Week
Rutgers Cancer Institute of New Jersey

April 20 "“ 26 is National Minority Cancer Awareness Week, a period highlighted by cancer facilities across the country due to high cancer incidence and death rates for these populations living in the U.S. Experts are available for comment on the prevention, treatment and detection of cancer for these groups.

4-Apr-2008 1:00 PM EDT
Implications for Fine-Tuned Breast Cancer Prognosis Unveiled
Rutgers Cancer Institute of New Jersey

With 40,000 breast cancer deaths expected in the U.S. this year, cancer researchers continue with their mission to unlock the mysteries surrounding this disease. Implications for fine-tuned prognosis for breast cancer patients were unveiled at the annual AACR meeting in San Diego April 12 "“ 16.

4-Apr-2008 1:00 PM EDT
Treatment Implications for Melanoma with ALS Drug Explored
Rutgers Cancer Institute of New Jersey

Future treatment implications for melanoma and ovarian cancer were discussed at the annual AACR meeting in San Diego April 12 "“ 16. Use of the ALS drug Riluzole on melanoma and the effects of the mineral selenium on ovarian cancer when combined with the standard of care were among highlighted studies presented.

Released: 11-Apr-2008 1:00 PM EDT
The Unofficial Arrival of Summer Could Spell Skin Trouble
Rutgers Cancer Institute of New Jersey

More than one million people nationwide are affected by skin cancer each year. This year alone, 68,000 new cases are projected, with a majority being classified as the most serious type "“ melanoma. As Memorial Day Weekend and the opening of the summer beach season fast approaches, prevention is key.

Released: 14-Apr-2008 4:15 PM EDT
Cancer Center Celebrates National Library Week
Rutgers Cancer Institute of New Jersey

When one thinks of collections of books, a public library may come to mind. But during this National Library Week, one of the country's top cancer centers gets to highlight it's very own on-site library, where cancer-related materials are made available to patients and the community at large.

Released: 16-May-2008 2:40 PM EDT
New Treatment Implications for Ovarian Cancer Unveiled
Rutgers Cancer Institute of New Jersey

New research findings indicate the potential for more targeted treatment of ovarian cancer through the use of the mineral selenium in combination with the standard treatment for the disease.

3-Jul-2008 12:00 PM EDT
Survival Benefit Lacks for Some Prostate Patients Given Hormones
Rutgers Cancer Institute of New Jersey

New research to be published in JAMA shows a lack of survival benefit for older men with localized prostate cancer when administered a common hormone therapy. Authors say the treatment did not show any increase in the overall survival rate compared to conservative management.

Released: 3-Jul-2008 12:30 PM EDT
Healthy Eating Tips for the Summer Barbecue Season
Rutgers Cancer Institute of New Jersey

With July being "Health-Promoting Lifestyles for Cancer Prevention Month," cancer experts are available to discuss the role of healthy eating for the summer barbecue season.

Released: 26-Aug-2008 3:30 PM EDT
Cancer Clinical Trial Info at Your Fingertips
Rutgers Cancer Institute of New Jersey

Upcoming Stand Up To Cancer campaign being used as springboard for discussion to remind and further educate cancer patients about a comprehensive website listing of all cancer clinical trials in New Jersey. Experts available to discuss need and benefit of such a resource.

Released: 4-Sep-2008 10:45 AM EDT
Scientists ‘Stand Up To Cancer’ with Latest Research
Rutgers Cancer Institute of New Jersey

The Stand Up To Cancer campaign is opening the nation's eyes to the need and the benefit of cancer research dollars. Top cancer experts are embarking on groundbreaking research, which include a look at active surveillance therapy in prostate cancer and investigation of the mineral selenium in ovarian cancer.

Released: 4-Sep-2008 10:55 AM EDT
September 13th is National Childhood Cancer Awareness Day
Rutgers Cancer Institute of New Jersey

While rare, 10,700 cases of childhood cancer will be diagnosed this year. Great strides in comprehensive care for such patients have been made, helping to keep the five-year survival rate for this group at 80 percent and trending upward. Experts can discuss unique programs that benefit this population.

Released: 8-Sep-2008 11:25 AM EDT
Bioinformatics, Zebrafish: The Future of Cancer Research
Rutgers Cancer Institute of New Jersey

With the Stand Up To Cancer telethon having raised millions of dollars, now the real work begins on applying that money toward the next generation of cancer research. Experts can discuss the latest in cutting-edge research in the areas of bioinformatics, work with zebrafish and survivorship issues.

Released: 26-Sep-2008 1:00 PM EDT
Triple Negative Breast Cancer Targeted in Clinical Trial
Rutgers Cancer Institute of New Jersey

Researchers are investigating a new combination of chemotherapy drugs targeted at patients who have been diagnosed with previously untreated triple-negative metastatic breast cancer.

Released: 26-Sep-2008 1:00 PM EDT
Partial Breast Radiation Focus of New Cancer Study
Rutgers Cancer Institute of New Jersey

Researchers are investigating whether partial breast radiation following a lumpectomy will hold a better benefit than radiation of the whole breast. Under Accelerated Partial Breast Irradiation, patients will receive radiation to only a portion of their breast over a three-week period versus the traditional six or seven.

Released: 26-Sep-2008 1:00 PM EDT
October is Breast Cancer Awareness Month
Rutgers Cancer Institute of New Jersey

Research in the areas of triple-negative breast cancer, breast brachytherapy, partial breast radiation and education on the benefits of breast self-exams and programs for young women with breast cancer are at focus during October, which is National Breast Cancer Awareness Month.

Released: 6-Oct-2008 11:50 AM EDT
Pink Ribbon Bagels Promote Breast Cancer Awareness
Rutgers Cancer Institute of New Jersey

One can start the day with a "˜cup of joe' and a good deed through the purchase of a Pink Ribbon Bagel from Panera Bread. A portion of the proceeds from the specialty item will support breast cancer programs at New Jersey's only National Cancer Institute Designated-Comprehensive Cancer Center.

Released: 27-Oct-2008 2:25 PM EDT
November is National Lung Cancer Awareness Month
Rutgers Cancer Institute of New Jersey

Some 161,000 lung cancer deaths are expected in the U.S. in 2008, which accounts for nearly a third of all cancer deaths. Experts can discuss risks, treatment and prevention options during this Lung Cancer Awareness Month, including the topics of palliative care and genetic marker study.

Released: 27-Oct-2008 2:30 PM EDT
November is Pancreatic Cancer Awareness Month
Rutgers Cancer Institute of New Jersey

Pancreatic cancer is the fourth leading cancer killer in the country. Experts are available to discuss risks, treatment and prevention options during this National Pancreatic Cancer Awareness Month, including immune therapy and the benefits of comprehensive care.

Released: 5-Nov-2008 5:15 PM EST
November 9 - 15 is National Nurse Practitioner Week
Rutgers Cancer Institute of New Jersey

The caring and curing efforts of over 125,000 nurse practitioners will be recognized during National Nurse Practitioner Week, which begins November 9. Some 600 million visits are made annually to NP's, who provide direct clinical care to patients as well as engage in health education and research.

Released: 24-Nov-2008 12:00 PM EST
December is Cancer-Related Fatigue Awareness Month
Rutgers Cancer Institute of New Jersey

Fatigue is a distressing side effect of cancer and can affect one's sense of well-being and even compliance with treatment. During this Cancer-Related Fatigue Awareness Month, experts are available to discuss this condition, which can become more prevalent during the busy holiday season.

Released: 9-Dec-2008 11:55 AM EST
Making the Cancer Journey More Comfortable for Teens
Rutgers Cancer Institute of New Jersey

Giving teens with cancer a place of their own while undergoing treatment, the Alicia Rose Victorious Foundation once again helps provide comfort with a generous gift to refurbish the "teen lounge" at one of the nation's Comprehensive Cancer Centers.

Released: 11-Dec-2008 12:20 PM EST
Clinical Trial Focuses on New Drug for Solid Cancer Tumors and NHL
Rutgers Cancer Institute of New Jersey

An NCI-sponsored clinical trial looks at an experimental DNA repair drug in combination with a chemotherapy agent for treatment of solid cancer tumors and non-Hodgkin's lymphoma.

Released: 11-Dec-2008 1:15 PM EST
January is Cervical Health Awareness Month
Rutgers Cancer Institute of New Jersey

Nearly 4,000 women nationwide will die of cervical cancer by the end of this year. The spotlight shines on this topic for the month of January. Experts are available to discuss overall cervical health awareness including cancer risk factors and prevention options.

Released: 23-Dec-2008 10:00 AM EST
NJ Researcher Captures $770K to Study Protein in Melanoma
Rutgers Cancer Institute of New Jersey

A New Jersey researcher has received an American Cancer Society Grant to investigate melanoma development with the hope of interrupting cell division or eliminating those cells. Through the study of a certain protein, the team hopes the information will also lead to the identification of a new prognostic marker for the disease.

Released: 5-Jan-2009 5:00 PM EST
Team Finds Breast Cancer Gene Linked to Disease Spread
Rutgers Cancer Institute of New Jersey

Scientists at two New Jersey institutions have identified a long-sought gene responsible for metastasis in 30 to 40 percent of all breast cancer patients. The research, published in the January 6 edition of Cancer Cell, also describes how this gene is resistant to traditional chemotherapy treatments.

Released: 15-Jan-2009 11:05 AM EST
Cancer Survivor Needs Examined Beyond Specialized Care
Rutgers Cancer Institute of New Jersey

By the year 2050 there will be more cancer survivors in the United States than those newly diagnosed with the disease. That is why researchers are taking a closer look at the specific needs of cancer survivors as they transition from specialty care back to their primary care provider.

Released: 28-Jan-2009 2:40 PM EST
In-Person Consult Desired When Learning of Breast Cancer Risk
Rutgers Cancer Institute of New Jersey

If you were being told that you were at genetic risk of developing breast cancer, would you want to find out over the phone? New research finds convenience plays a large role in the answer to that question.

Released: 30-Jan-2009 11:40 AM EST
Shift Workers’ Body Clocks Studied to Prevent Certain Cancers
Rutgers Cancer Institute of New Jersey

Does shift work predispose one to breast or prostate cancer by altering the body's response to hormones? And if so, can a dietary supplement help? Those are the questions researchers hope to answer through a new study which looks at the effects of this supplement on one's circadian rhythm.

Released: 2-Feb-2009 1:10 PM EST
February is Cancer Screening and Early Detection Month
Rutgers Cancer Institute of New Jersey

February is Screening and Early Detection for Cancer Month. Abnormal cells that can become cancer cells can be detected through a variety of tests, many of which are recommended on a regular basis based on age, general health and overall risk factors.

Released: 2-Feb-2009 1:40 PM EST
New Method of Robotic Prostatectomy Shows Multiple Benefits
Rutgers Cancer Institute of New Jersey

A new robotic surgical technique developed for the removal of all or part of the prostate gland is showing what investigators call a "dramatic improvement" in a male's sexual potency rate. The results were recently presented at the 26th World Congress Endourology meeting in Shanghai, China.

Released: 4-Feb-2009 3:00 PM EST
Gift Provides Latest in Optical Technology for NJ Cancer Center
Rutgers Cancer Institute of New Jersey

New Jersey's only NCI-designated Comprehensive Cancer Center soon will have access to unique imaging technology right at its fingertips, thanks to a generous gift from the J. Seward Johnson, Sr. 1963 Charitable Trust. The new machinery will provide researchers with enhanced visualization of cancer cells.

Released: 6-Feb-2009 4:45 PM EST
Building Bioinformatics Collaborations for Health Care Research
Rutgers Cancer Institute of New Jersey

As advanced technology continues to allow for the simplification and collection of health care and research data, experts want to streamline that process. Two New Jersey institutions brought together intellectual leaders to address challenges in the gathering and analysis of health care information for the benefit of patients.

Released: 10-Feb-2009 3:00 PM EST
Global HER2 Positive Breast Cancer Trial Opens in NJ
Rutgers Cancer Institute of New Jersey

New Jersey's only NCI-designated Comprehensive Cancer Center is taking part in a worldwide clinical trial targeting HER2 positive breast cancer, which accounts for up to 25 percent of all breast cancers. Investigators will look at multiple combinations of the drugs Lapatinib and Trastuzumab.

Released: 13-Feb-2009 2:40 PM EST
New Trial Targets Kidney Cancer Drug in Bladder Cancer
Rutgers Cancer Institute of New Jersey

Nearly 70,000 cases of bladder cancer were diagnosed nationwide last year. That's why researchers are looking at an FDA-approved treatment for kidney cancer when combined with the standard of care for bladder cancer. At focus is one of the newer "targeted therapies" known as sorafenib.

Released: 26-Feb-2009 8:45 PM EST
March is National Colorectal Cancer Awareness Month
Rutgers Cancer Institute of New Jersey

Colorectal cancer is the third most common type of cancer in men and women and is the third leading cause of cancer death in the nation. Nearly 149,000 new cases of the disease were diagnosed nationwide last year. Experts from New Jersey's only NCI-designated Comprehensive Cancer Center are available for comment.

Released: 26-Feb-2009 8:45 PM EST
March is National Professional Social Work Month
Rutgers Cancer Institute of New Jersey

Social workers are society's safety net, providing vital resources and support when they are most needed, particularly, the psychosocial needs of oncology patients. Experts from New Jersey's only NCI-designated Comprehensive Cancer Center are available for comment on the unique support social workers provide for those with cancer.

Released: 16-Mar-2009 11:40 AM EDT
Kidney, Liver Cancer Drug Tested in New Combination for Breast Cancer
Rutgers Cancer Institute of New Jersey

A clinical trial to evaluate a new treatment for metastatic breast cancer in combination with one that is already approved for liver and kidney cancers is underway at New Jersey's only NCI-designated Comprehensive Cancer Center. Researchers will test the effectiveness of sorafenib when paired with letrozole.

Released: 19-Mar-2009 11:55 AM EDT
Lung Cancer Experts Address Smoking Dangers on Kick Butts Day
Rutgers Cancer Institute of New Jersey

Statistics show 90 percent of smokers start before age 21. That is why youth nationwide will raise awareness about tobacco use on March 25th during the 14th annual Kick Butts Day. Experts at New Jersey's only NCI-designated Comprehensive Cancer Center are available for comment on the development of lung cancer and other related effects of smoking.

19-Mar-2009 1:30 PM EDT
Young Hodgkin's Patients Benefit from Breast, Lung Drug Combo
Rutgers Cancer Institute of New Jersey

New research published in the Journal of Clinical Oncology shows a treatment combination used in breast and lung cancers to be effective against Hodgkin's disease in pre-teens and young adults, which make up to 10 to 15 of all U.S. cases. At focus are the drugs Gemcitabine and Vinorelbine.

Released: 23-Mar-2009 10:15 AM EDT
Study Looks at Celebrex and Lipitor to Treat Prostate Cancer
Rutgers Cancer Institute of New Jersey

Researchers are looking at the drugs Celebrex and Lipitor, used respectively for arthritis pain and lowering one's cholesterol, to see if they can slow or stop the growth of prostate cancer when combined. The new study has just opened at New Jersey's only NCI-designated Comprehensive Cancer Center.

Released: 3-Apr-2009 1:00 PM EDT
Cancer Resource Center Feted During National Library Week
Rutgers Cancer Institute of New Jersey

New Jersey's only NCI-designated Comprehensive Cancer Center is celebrating the contributions of its Resource and Learning Center during National Library Week (April 12 "“ 18). This center provides unique books and audio/visual aids to both patients and the public to further educate them about the disease.

Released: 3-Apr-2009 1:00 PM EDT
April is National Cancer Control Awareness Month
Rutgers Cancer Institute of New Jersey

New Jersey's only NCI-designated Comprehensive Cancer Center is highlighting its clinical trial program during this National Cancer Control Awareness Month. One of the components experts focus on is the importance of having access to trial information right at one's fingertips.

Released: 3-Apr-2009 1:00 PM EDT
Bioinformatics, Zebrafish at Focus During Cancer Control Month
Rutgers Cancer Institute of New Jersey

During this National Cancer Control Month, New Jersey's only NCI-designated Comprehensive Cancer Center is focusing on unique research efforts taking place at its facility. Biomedical informatics, work with zebrafish and study of circadian rhythms and survivorship issues are among the highlights experts can discuss.

Released: 2-Apr-2009 8:45 PM EDT
Having Synchronous Cancers Means Better Survival Outcome
Rutgers Cancer Institute of New Jersey

A new study shows better survival outcomes for women who have ovarian and endometrial cancers at the same time than those who only have one tumor in the ovaries. The research from New Jersey's only Comprehensive Cancer Center is published in the April edition of Obstetrics and Gynecology.

Released: 13-Apr-2009 2:20 PM EDT
NJ Cancer Survivor Program Aided By Lance Armstrong Foundation
Rutgers Cancer Institute of New Jersey

Thanks to the Lance Armstrong Foundation, New Jersey's only Comprehensive Cancer Center will expand a clinical program that meets the unique needs of cancer survivors. The $100,000 grant will fund an education program for healthcare workers, who are on the front lines in helping survivors meet various challenges.

16-Apr-2009 11:25 AM EDT
Fulvestrant-Chemo Combo Targeted for ER Positive Breast Cancer
Rutgers Cancer Institute of New Jersey

Researchers from New Jersey's only NCI-designated Comprehensive Cancer Center are presenting findings on a combined treatment targeting breast cancer that is stimulated by the hormone estrogen. At focus is how the FDA-approved therapy fulvestrant can influence the effects of chemotherapy drugs on breast cancer cells.

16-Apr-2009 11:25 AM EDT
Tumor Environment Targeted in Understanding Cancer Growth
Rutgers Cancer Institute of New Jersey

New Jersey researchers are presenting findings on the interaction between a tumor cell and its environment, and how manipulation of those surroundings can lead to new targeted cancer therapies. At focus are mesenchymal stromal cells, which make up the outer connective tissue of a cancer tumor.

Released: 30-Apr-2009 3:30 PM EDT
New Jersey Oncology Nurses Showcase Research at National Meeting
Rutgers Cancer Institute of New Jersey

Since Florence Nightingale worked to improve the medical conditions of soldiers, nursing has progressed into a profession of caregivers with both clinical knowledge and technical expertise. Continually building on this proud tradition, nurses at New Jersey's only NCI-designated Comprehensive Cancer Center highlight their research before their peers.


close
1.21252